Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Respir J ; 39(3): 604-10, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21737555

RESUMO

The A/H1N1 influenza strain isolated in Mexico in 2009 caused severe pulmonary illness in a small number of exposed individuals. Our objective was to determine the influence of genetic factors on their susceptibility. We carried out a case-control association study genotyping 91 patients with confirmed severe pneumonia from A/H1N1 infection and 98 exposed but asymptomatic household contacts, using the HumanCVD BeadChip (Illumina, San Diego, CA, USA). Four risk single-nucleotide polymorphisms were significantly (p<0.0001) associated with severe pneumonia: rs1801274 (Fc fragment of immunoglobulin G, low-affinity IIA, receptor (FCGR2A) gene, chromosome 1; OR 2.68, 95% CI 1.69-4.25); rs9856661 (gene unknown, chromosome 3; OR 2.62, 95% CI 1.64-4.18); rs8070740 (RPA interacting protein (RPAIN) gene, chromosome 17; OR 2.67, 95% CI 1.63-4.39); and rs3786054 (complement component 1, q subcomponent binding protein (C1QBP) gene, chromosome 17; OR 3.13, 95% CI 1.89-5.17). All SNP associations remained significant after adjustment for sex and comorbidities. The SNPs on chromosome 17 were in linkage disequilibrium. These findings revealed that gene polymorphisms located in chromosomes 1 and 17 might influence susceptibility to development of severe pneumonia in A/H1N1 infection. Two of these SNPs are mapped within genes (FCGR2A, C1QBP) involved in the handling of immune complexes and complement activation, respectively, suggesting that these genes may confer risk due to increased activation of host immunity.


Assuntos
Variação Genética , Vírus da Influenza A Subtipo H1N1 , Influenza Humana/genética , Pneumonia Viral/genética , Adulto , Proteínas de Transporte/genética , Estudos de Casos e Controles , Cromossomos Humanos Par 1 , Cromossomos Humanos Par 17 , Feminino , Predisposição Genética para Doença , Humanos , Influenza Humana/imunologia , Desequilíbrio de Ligação , Masculino , México , Pessoa de Meia-Idade , Proteínas Mitocondriais/genética , Pneumonia Viral/imunologia , Polimorfismo de Nucleotídeo Único , Receptores de IgG/genética , Índice de Gravidade de Doença , Adulto Jovem
2.
J Exp Med ; 193(9): 1087-96, 2001 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-11342593

RESUMO

Antigen-specific CD4 T helper type 2 (Th2) cells play a pivotal role in the induction of allergic asthma, but the mechanisms regulating their recruitment into the airways are unknown. Signal transducer and activator of transcription factor (Stat)6 is a transcription factor essential for Th2 cell differentiation. Here we show that Stat6 also controls Th2 cell recruitment and effector function in allergic inflammation in vivo. To isolate the role of Stat6 in regulating Th2 cell trafficking and effector function from its role in Th2 cell differentiation, we used a murine model of asthma in which in vitro-differentiated Stat6(+/+) antigen-specific Th2 cells were adoptively transferred into naive Stat6(-/-) and Stat6(+/+) mice followed by aerosol antigen challenge. We found that all of the features of asthma, including Th2 cell accumulation, Th2 and eosinophil-active chemokine production, and airway eosinophilia, mucus production, and hyperresponsiveness seen in Stat6(+/+) mice, were dramatically absent in Stat6(-/)- mice that received Stat6(+/)+ antigen-specific Th2 cells. Our findings establish Stat6 as essential for Th2 cell trafficking and effector function and suggest that interruption of Stat6 signaling in resident cells of the lung is a novel approach to asthma therapy.


Assuntos
Transdução de Sinais/imunologia , Células Th2/imunologia , Transativadores/imunologia , Ativação Transcricional , Animais , Antígenos/imunologia , Hiper-Reatividade Brônquica/imunologia , Líquido da Lavagem Broncoalveolar/imunologia , Quimiocinas/genética , Citocinas/genética , Eosinófilos/imunologia , Perfilação da Expressão Gênica , Células Caliciformes/metabolismo , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Camundongos Transgênicos , Muco/metabolismo , Ovalbumina/imunologia , Fator de Transcrição STAT6 , Transativadores/genética
3.
Circ Res ; 88(8): 832-8, 2001 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-11325876

RESUMO

Sepsis and endotoxemia impair hypoxic pulmonary vasoconstriction (HPV), thereby reducing systemic oxygenation. To assess the role of leukotrienes (LTs) in the attenuation of HPV during endotoxemia, the increase in left lung pulmonary vascular resistance (LPVR) before and during left mainstem bronchus occlusion (LMBO) was measured in mice with and without a deletion of the gene encoding 5-lipoxygenase (5-LO). LMBO increased the LPVR equally in saline-challenged wild-type and 5-LO-deficient mice (96+/-20% and 94+/-19%, respectively). Twenty-two hours after challenge with Escherichia coli endotoxin, the ability of LMBO to increase LPVR was markedly impaired in wild-type mice (27+/-7%; P<0.05) but not in 5-LO-deficient mice (72+/-9%) or in wild-type mice pretreated with MK886, an inhibitor of 5-LO activity (76+/-10%). Compared with wild-type mice, endotoxin-induced disruption of lung structures and inflammatory cell influx in the lung were markedly attenuated in 5-LO-deficient mice. Administration of MK571, a selective cysteinyl LT(1) receptor antagonist, 1 hour before endotoxin challenge preserved HPV and attenuated pulmonary injury in wild-type mice but did not prevent the endotoxin-induced increase in pulmonary myeloperoxidase activity. Taken together, these findings demonstrate that a 5-LO product, most likely a cysteinyl LT, contributes to the attenuation of HPV and to pulmonary injury after challenge with endotoxin.


Assuntos
Araquidonato 5-Lipoxigenase/metabolismo , Endotoxemia/metabolismo , Hipóxia/fisiopatologia , Proteínas de Membrana , Circulação Pulmonar , Receptores de Leucotrienos , Resistência Vascular , Vasoconstrição , Administração por Inalação , Animais , Araquidonato 5-Lipoxigenase/deficiência , Líquido da Lavagem Broncoalveolar/química , Modelos Animais de Doenças , Endotoxemia/induzido quimicamente , Endotoxemia/complicações , Endotoxinas/farmacologia , Inibidores Enzimáticos/farmacologia , Hemodinâmica/efeitos dos fármacos , Hipóxia/complicações , Hipóxia/enzimologia , Contagem de Leucócitos , Antagonistas de Leucotrienos/farmacologia , Leucotrienos/análise , Inibidores de Lipoxigenase/farmacologia , Pulmão/irrigação sanguínea , Pulmão/efeitos dos fármacos , Pulmão/patologia , Camundongos , Camundongos Mutantes , Óxido Nítrico/administração & dosagem , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Peroxidase/metabolismo , Alvéolos Pulmonares/irrigação sanguínea , Alvéolos Pulmonares/metabolismo , Circulação Pulmonar/efeitos dos fármacos , Circulação Pulmonar/fisiologia , Resistência Vascular/efeitos dos fármacos , Resistência Vascular/fisiologia , Vasoconstrição/efeitos dos fármacos , Vasoconstrição/fisiologia
4.
J Exp Med ; 192(3): 439-46, 2000 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-10934232

RESUMO

Leukotriene B(4) (LTB(4)) is a potent chemoattractant active on multiple leukocytes, including neutrophils, macrophages, and eosinophils, and is implicated in the pathogenesis of a variety of inflammatory processes. A seven transmembrane-spanning, G protein-coupled receptor, called BLTR (LTB(4) receptor), has recently been identified as an LTB(4) receptor. To determine if BLTR is the sole receptor mediating LTB(4)-induced leukocyte activation and to determine the role of LTB(4) and BLTR in regulating leukocyte function in inflammation in vivo, we generated a BLTR-deficient mouse by targeted gene disruption. This mouse reveals that BLTR alone is responsible for LTB(4)-mediated leukocyte calcium flux, chemotaxis, and firm adhesion to endothelium in vivo. Furthermore, despite the apparent functional redundancy with other chemoattractant-receptor pairs in vitro, LTB(4) and BLTR play an important role in the recruitment and/or retention of leukocytes, particularly eosinophils, to the inflamed peritoneum in vivo. These studies demonstrate that BLTR is the key receptor that mediates LTB(4)-induced leukocyte activation and establishes a model to decipher the functional roles of BLTR and LTB(4) in vivo.


Assuntos
Fatores Quimiotáticos/imunologia , Quimiotaxia de Leucócito , Eosinófilos/imunologia , Leucotrieno B4/imunologia , Peritonite/imunologia , Receptores do Leucotrieno B4/imunologia , Animais , Cálcio/metabolismo , Adesão Celular , Modelos Animais de Doenças , Eosinófilos/fisiologia , Marcação de Genes , Macrófagos Peritoneais/imunologia , Macrófagos Peritoneais/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Músculos/irrigação sanguínea , Neutrófilos/imunologia , Neutrófilos/metabolismo , Peritonite/induzido quimicamente , Receptores do Leucotrieno B4/genética , Tioglicolatos/imunologia , Tioglicolatos/farmacologia , Vênulas
5.
J Leukoc Biol ; 66(6): 901-8, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10614770

RESUMO

Pulmonary macrophages (Mphi) increase in tissue and bronchoalveolar lavage (BAL) fluid during inflammation caused by bleomycin (BLM). This study demonstrates that increasing numbers of exudate Mphi in BLM lung injury exhibit dendritic cell (DC) features. After the intratracheal administration of BLM (0.075 U), adherent mononuclear cells from the bronchoalveolar lavage fluid (BAMC) of C57BL/6 mice were characterized for morphology, immunophenotype, and accessory cell activities. At day 7 post-BLM, 48% of CD11b+ BAMC displayed features of DC differentiation, as judged by dendritic morphology, expression of class II MHC, 33D1, Factor XIIIa, CD80, and CD86 antigens, and the ability to support a primary allogeneic lymphocyte response (MLR). After BLM treatment, CD11b+ peripheral blood monocytes also showed increased expression of 33D1, Factor XIIIa, CD86, and the ability to stimulate an MLR. We conclude that inflammatory DC with immunophenotypic features of monocyte-derived DC increase in the peripheral blood and lung after an inflammatory stimulus.


Assuntos
Movimento Celular/imunologia , Células Dendríticas/imunologia , Pulmão/patologia , Monócitos/imunologia , Pneumonia/patologia , Animais , Antígenos de Superfície/biossíntese , Antígeno B7-1/biossíntese , Bleomicina/toxicidade , Líquido da Lavagem Broncoalveolar , Células Cultivadas , Galinhas , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/patologia , Exsudatos e Transudatos/citologia , Feminino , Imunofenotipagem , Pulmão/efeitos dos fármacos , Pulmão/imunologia , Teste de Cultura Mista de Linfócitos , Antígeno de Macrófago 1/biossíntese , Macrófagos Alveolares/efeitos dos fármacos , Macrófagos Alveolares/imunologia , Macrófagos Alveolares/patologia , Camundongos , Camundongos Endogâmicos C57BL , Monócitos/citologia , Monócitos/efeitos dos fármacos , Pneumonia/sangue , Pneumonia/induzido quimicamente , Pneumonia/imunologia
6.
Am J Respir Cell Mol Biol ; 19(4): 643-52, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9761762

RESUMO

Recently, some investigators have observed elevated concentrations of chloride in the airway surface fluid (ASF) overlying respiratory epithelia from cystic fibrosis (CF) patients compared with ASF overlying non-CF epithelia. Others have shown that this elevated ASF salt concentration can inactivate human beta-defensin-1, an antimicrobial peptide secreted by respiratory epithelia. This could impair the primary epithelial defense against bacteria in the CF airway, thereby forcing a greater reliance on polymorphonuclear leukocyte (PMN)-mediated defenses. Pseudomonas aeruginosa (Psa) flourishes in the CF airway despite the presence of abundant PMN. We therefore investigated whether elevated ASF chloride concentration in CF might also compromise PMN function. We employed a cell-culture model in which halide concentrations and osmolarity were varied independently. We examined the effects of chloride concentration on three aspects of PMN function: recruitment of PMN to the airway (production of interleukin-8 [IL-8]), PMN antimicrobial activity (killing of Psa), and PMN clearance from the airways (apoptosis and lysis). We found that exposure to elevated chloride concentration increased PMN synthesis of IL-8, decreased PMN killing of Psa, and accelerated PMN apoptosis and lysis. In CF airways, elevated chloride therefore could contribute to the increased number of PMN recruited into the airways, the increased survival of Psa, and the increased quantity of toxic mediators released by PMN into the airways. These effects of elevated chloride on PMN function may provide another causal link between loss of cystic fibrosis transmembrane conductance regulator function and CF lung disease.


Assuntos
Cloretos/farmacologia , Fibrose Cística/imunologia , Fibrose Cística/metabolismo , Ativação de Neutrófilo/efeitos dos fármacos , Adulto , Apoptose/imunologia , Células Cultivadas , Relação Dose-Resposta a Droga , Humanos , Interleucina-8/biossíntese , Pulmão/citologia , Ativação de Neutrófilo/imunologia , Neutrófilos/citologia , Neutrófilos/metabolismo , Neutrófilos/microbiologia , Fagocitose/imunologia , Pneumonia/imunologia , Pneumonia/metabolismo , Pseudomonas aeruginosa/imunologia
7.
Crit Care Nurs Clin North Am ; 8(3): 273-92, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9095802

RESUMO

This article summarizes the complications of lung transplantation. Complications discussed are categorized into (1) complications of the operation itself, including hemorrhage, the reimplantation response, airway anastomotic complications, cardiac and hemodynamic complications, and gastrointestinal complications; (2) complications of transplantation, including acute and chronic rejection; and (3) complications of the immunosuppressive agents used to prevent rejection, including infection, malignancy, and direct toxicities of the medications. This article describes the usual presenting features of these complications and summarizes strategies used by transplant providers for their prevention, early diagnosis, and treatment.


Assuntos
Transplante de Pulmão/efeitos adversos , Cuidados Críticos , Rejeição de Enxerto/etiologia , Hemorragia/etiologia , Humanos , Imunossupressores/efeitos adversos , Infecções/etiologia , Transplante de Pulmão/enfermagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...